廖新波:儿科医生价值不回归 这些措施都无济于事!

2016-02-26 廖新波 健康界

摘要: 儿科问题突出并非一朝一夕,顶层也早已经清楚。然而,大多数人并没有关注到为什么儿科医生短缺以及目前的执业环境所带来的更深层次的原因。 国家卫计委自从提出在医师资格考试中对儿科专业加试降分引起业内一片哗然之后,现在继续出招——“儿科医生不够内科医生上”、“协调恢复儿科招生”。继而,广州地区出台委托高校“订单式”定向培养儿科医生。这一系列“举措”在让人唏嘘的同时,也不免让

摘要:

儿科问题突出并非一朝一夕,顶层也早已经清楚。然而,大多数人并没有关注到为什么儿科医生短缺以及目前的执业环境所带来的更深层次的原因。

国家卫计委自从提出在医师资格考试中对儿科专业加试降分引起业内一片哗然之后,现在继续出招——“儿科医生不够内科医生上”、“协调恢复儿科招生”。继而,广州地区出台委托高校“订单式”定向培养儿科医生。这一系列“举措”在让人唏嘘的同时,也不免让人担忧。

其实,儿科问题突出并非一朝一夕,顶层也早已经清楚。儿科与精神医学、产科、康复、病理、药学、老年医学、老年护理等被列为2016年要解决的紧缺人才的重点。《2015年中国卫生统计年鉴》显示,近5年来,我国儿科医生总数从10.5万下降到10万,平均每千名儿童只有0.43位儿科医生,与全国平均每***配备2.06名医师相较甚远。有人测算过,早在几年前,我国的儿科医生缺口就是20万。

而今,随着国家实施全面二孩政策,儿科医生紧缺的问题越来越凸显,引发社会高度关注。可以说,是“社会压力”把儿科医生短缺的问题推向社会的问题焦点,儿童的看病问题也许将面临新的挑战。也可以这么说,大多数人并没有关注到为什么儿科医生短缺以及目前的执业环境所带来的更深层次的原因。

要解决这个问题并非那么简单,需要从长计议,更需要找出儿科医生短缺的根因。针对当前大家对儿科的几个热点问题,现分述如下:

首先,“恢复儿科招生”之类的想法不是解决问题的关键,甚至要问意义何在?如果市场是完善的,或者“定向分配”的,那么儿科从本科就开始专业化的定向培养可能也是一个办法。但是,有两点需要我们研究。一是为什么17年前(1999年)某些院校停止儿科本科招生,是行政的问题还是市场的问题?

二是没有定向培养的1998年及之前,有没有出现儿科医生如此短缺?市场经济的美国也没有从本科就定向培养,但他们的***儿科医生数却是1.6。何况,《中庸》有云:“博学之,审问之,慎思之,明辨之,笃行之。”为落实科教兴国战略,提高全民族素质,自高校扩招以来,拓宽专业口径,部分专业被调整与合并,本科教育更加侧重于“博学”,即通识教育,研究生教育才是专注于专业化教育。

原本的儿科本科专业被并进临床医学专业,到研究生阶段才细分出儿科专业,符合由通识教育到专业化教育的教育改革与发展,也符合医学教育由系统到专科的培养。而且,其他被并进本科临床医学专业的学科以及临床医学下的许多学科并没有出现儿科这样的艰难处境,如外科、眼科、皮肤科等。因此,停止本科教育是当前儿科医生短缺的缘由确实值得商榷。

广州“订单式”定向培养儿科医生也许是一个解决儿科医生“适销对路”的办法,与美国儿科医生的培养异曲同工。美国的医生是在读完“全科”之后,从住院医生时开始选择专科与定向。只要经过了儿科医生住院医训练计划,出来的就是儿科医生。

至于儿科里的专科如儿科放射、儿科麻醉、儿科普外等,则在做专科培训的前、中、后加入更多儿科轮转。如儿科神经内科,一般在至少两年、大多三年儿科全科之后,再进行两年儿科神经专科fellow训练。由此可见,儿科医生的成熟培训与经验积累更为重要。像“儿科不足内科上”,不仅仅是法律问题,还是专业技术问题。

其次,“恢复儿科招生”、“内科转儿科”是一个一厢情愿的问题。目前,我们医生的教育培养与就业完全是市场行为,政府完全没有“指派”能力。因而,报与不报儿科专业、转与不转儿科专业,涉及的因素很多,其中就包括业内对儿科专业的认识。我想,在儿科医生“纷纷”逃离的现在,谁还有“舍我其谁”的大无畏精神呢?再说“订单式培养”之下,由谁出钱,培养出来又如何使用,如何稳定队伍?这些都是很现实的问题。

邻省一位主管医政的领导曾对我说:“廖厅,我不再送医生到广州进修了……”为什么?因为送来培训的都是优秀医生,可大部分如同“肉包子打狗有去无回”。停招儿科本科专业的这17年包括新医改的7年,并且新医改中也有“加强儿科等专业人才培养”的说辞,但实际上,在医疗市场无序的状态下,公立医院无法实现公益性,也只能是目前这种状态了!

第三,要考虑儿科医生的出路问题。出路,无非就是待遇与就业环境。待遇,与我们公立医院的分配制度和医保的支付制度有着密切的关系。目前,公立医院的分配制度完全处于“分产到户,自食其力”的状态。儿科病的特点之一就是起病急、病程短,更多的是靠医生的判断能力,但这种“看不见”的价值往往不被人们认可。因此,儿科医生的价值与其他医生的价值一样基本被“抹杀”,加上儿科医生依靠检查、药品“维生”不如其他专业,“创收”能力差,待遇更是雪上加霜。

这种情况越到基层越明显,也造成了儿科医生大多数只能在专科医院或大医院谋生,基层儿科医疗服务能力不足。可即使在专科医院或大医院,他们也只能是通过“薄利多销”来维持“体面”的收入。正是由于不完善的“市场”、医疗资源的配置无力、过度的集中等,造成了当前儿科实际的缺员。

总而言之,儿科医生困境是当前“市场化”环境下,医生择业(择专业)的一个缩影,已经产生蝴蝶效应。尽管培养医生的形式可以多种多样,但是“产销、适销对路”才是“产”的因由、“销”的出口。如果儿科专业或其他如麻醉专业等培养出来的“产品”“销”得好,则相安无事;如果“销”不好,那么由于知识面窄,医生不好“转型”。不仅如此,在僵硬的“市场准入”和恶劣的执业环境下,还会迫使这些专业的医生转行。因此,问题最关键的是——医生价值不回归,这几条措施将无济于事!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-06 wei834766788

    有道理

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-03 slicer

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-03-01 田田1746

    是的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 1de3b290m83(暂无匿称)

    一言难尽

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 wei834766788

    价值会回

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 wei834766788

    回归

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 wei834766788

    有道理

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2080725, encodeId=abbf2080e25e9, content=<a href='/topic/show?id=7e1c49494e5' target=_blank style='color:#2F92EE;'>#廖新波#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49494, encryptionId=7e1c49494e5, topicName=廖新波)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jan 21 00:12:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030696, encodeId=edc92030696c2, content=<a href='/topic/show?id=a4e5345207f' target=_blank style='color:#2F92EE;'>#医生价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34520, encryptionId=a4e5345207f, topicName=医生价值)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQBvJI9WesEs5nl29JIJ7mAquShibzBHQmTeHHwZMDlIzc5qoQUhTJOpOwiaxYa9UcibrZviaM7dL7aQ/132, createdBy=35cb2500499, createdName=ms1343860338762272, createdTime=Thu Dec 29 08:12:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67713, encodeId=6bdc6e71341, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Mar 06 23:58:00 CST 2016, time=2016-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67014, encodeId=de476e01450, content=哎, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ba41656652, createdName=slicer, createdTime=Thu Mar 03 12:47:00 CST 2016, time=2016-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66387, encodeId=b2fa6638e34, content=是的, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42b01658905, createdName=田田1746, createdTime=Tue Mar 01 06:45:00 CST 2016, time=2016-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66243, encodeId=fff96624369, content=一言难尽, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Sun Feb 28 23:05:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66209, encodeId=b34d662091f, content=价值会回, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66210, encodeId=22d9662102b, content=回归, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:12:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66208, encodeId=20556620806, content=有道理, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Sun Feb 28 20:11:00 CST 2016, time=2016-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=66186, encodeId=aedf661869e, content=那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa6195464, createdName=haifanxingyang, createdTime=Sun Feb 28 16:48:00 CST 2016, time=2016-02-28, status=1, ipAttribution=)]
    2016-02-28 haifanxingyang

    那么多学药的,为啥说人才紧缺呢?呵呵~医院不招人,去药企了,工资太低了,转行了,呵呵~

    0

相关资讯

卫计委:加力培养儿科医师 2020年达14万

中国儿科医师短缺,特别是实行全面两孩政策后,儿科医疗保健需求将更为迫切。国家卫生计生委官员24日表示,将采取更有力的措施来加大儿科人才培养工作的力度,到2020年,力争使儿科医师达到14万人以上。 国家卫生计生委当天在北京举行新闻发布会,卫计委科技教育司副司长金生国介绍了相关情况。 据知,目前在执业(助理)医师中,儿科医师有11.28万人,占3.9%。中国儿童总数2.26亿,每千名儿童有0.5

熊丙奇:儿科医生荒是怎样造成的

进入全面二孩时代,儿科医生的紧缺受到越来越多的关注。据悉,国家卫计委已将此列为2016年的工作要点之一。这意味着从1999年起停招的儿科学专业将有望时隔17年后恢复本科招生,各界对此高度关注。事实上,近日就有多名四川省政协委员联名致信教育部,请求恢复本科专业目录中的儿科专业,增大人才培养力度,以缓解儿科医生荒的社会问题。 儿科医生荒究竟是怎样造成的?是因高校停招儿科本科专业?还是因儿科专业毕业生

恢复儿科专业能缓解儿科荒吗

如今儿科医生短缺的原因,与本科阶段有没有专业教育,并无太大的关系。如何提高儿科的吸引力,让现有的医学生愿意选择到儿科领域中来,是比什么都重要的事情。

内科医生开出的元宵节处方:好好爱老婆

重庆医科大学儿童医院儿外科医生元宵节为了看望值夜间急诊的老婆,让上夜班的儿内科医生老婆休息5分钟,特意挂了个号!内科医生老婆开出了如下处方: 这是史上最浪漫的元宵节处方,传递爱、温情与正能量!也希望老百姓能够多理解医生,尤其是儿科医生! 老公一直想进去给她送水,等了半个小时都插不进去,想起那个老汉挂号见儿子的事情,就挂号进去,进去后老婆就喊老公出

复旦大学儿科学拟单列招生

全面二孩时代来临,儿科医生的紧缺越来越受关注。记者昨天获悉,未来几年内,复旦计划将儿科学方向在学校招生计划中单列,每年招生人数预计达到30名左右。 复旦上海医学院自2015年开始在5年制临床医学专业设立“儿科学方向”。未来几年内,计划将临床医学专业(儿科学方向)在学校招生计划中单列,每年招生人数预计达到30名左右。同时,还结合“5+3”(5年临床医学本科教育+3年住院医师规范化培训或3年临床医学

12省份计生新政出台,产假最长半年

12省份计生新政出台,福建省产假最长180天。专家建议恢复“托儿所”,为全民二胎做保障。 (数据来源于各地公开发表的《人口与计划生育条例》及新闻报道) 为全面实施两孩政策,各地相继开始修订地方计生条例,目前,天津、浙江、宁夏等12省份的新计生条例已经出台。经人民网编辑梳理发现,不同省份产假从最长的180天到最短的128天,可相差近两个月之多。而对于百姓担心的两孩生育相关保障问题,多名专家围